Unlimited_Turbo_46_20221/ DE000PE4FWZ8 /
2024-05-15 9:20:26 PM | Chg.-0.010 | Bid9:37:09 PM | Ask9:37:09 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.090EUR | -0.32% | 3.080 Bid Size: 1,400 |
3.120 Ask Size: 1,400 |
CTS EVENTIM KGAA | 49.6188 - | 2078-12-31 | Call |
GlobeNewswire
11:00 PM
GT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
11:00 PM
TC Energy to appeal Delaware court rulings in lawsuit related to 2016 Columbia Pipeline acquisition
GlobeNewswire
11:00 PM
Spring Oaks Capital, LLC Expanding to greater Albuquerque and Creating 200+ New Jobs
GlobeNewswire
11:00 PM
Peyto Exploration & Development Corp. Confirms Monthly Dividend for June 14, 2024
GlobeNewswire
11:00 PM
Quipt Home Medical Reports Second Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 10...
GlobeNewswire
11:00 PM
Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Cor...
GlobeNewswire
11:00 PM
Farmers & Merchants Bancorp (FMCB) Increases Cash Dividend for the 59th Consecutive Year
GlobeNewswire
11:00 PM
AGBA Solidifies Market Leadership with Expansion Plans and Focus on Tech/Fintech Innovation
GlobeNewswire
11:00 PM
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
10:47 PM
American Oncology Network, Inc. Announces First Quarter 2024 Financial Results
GlobeNewswire
10:45 PM
Delisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.G...
GlobeNewswire
10:45 PM
Semilux International Ltd. Announces Filing of Annual Report on Form 20-F for December 31, 2023
GlobeNewswire
10:43 PM
Gray Television Announces Commencement of Proposed $1.6 Billion Refinancing Process and a Further In...